Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2003
04/01/2003CA2254873C Electrochemical biosensors
04/01/2003CA2245108C Tandem fluorescent protein constructs
03/2003
03/28/2003CA2404723A1 Methods related to the a-c repeat z-sequence upstream from the aldose reductase gene
03/27/2003WO2003029411A2 Novel cyclooxygenase variants and methods of use
03/27/2003WO2003025627A2 Optical biosensor with enhanced activity retention for detection of halogenated organic compounds
03/27/2003WO2003025583A2 Differential diagnosis of disorders of iron metabolism
03/27/2003WO2003025579A2 Use of heart fatty acid binding protein
03/27/2003WO2003025575A1 Methods and compositions involving thymidine phosphorylase as a marker for hiv infection, aids progression, and drug resistance
03/27/2003WO2003025574A1 Embossed test strip system
03/27/2003WO2003025573A1 Multi-analyte assay device with multi-spot detection zone
03/27/2003WO2003025564A1 Method for evaluating a patient's biological condition
03/27/2003WO2003025558A1 Method, tool and device for measuring concentration
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025540A2 Differential tagging of polymers for high resolution linear analysis
03/27/2003WO2003025257A1 Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
03/27/2003WO2003025229A1 A method for identifying effector molecules for gene network integration
03/27/2003WO2003025227A1 Detection of rpob sequences of mycobacterium tuberculosis
03/27/2003WO2003025226A1 Method and apparatus for amplification of nucleic acid sequences by using thermal convection
03/27/2003WO2003025225A2 Pthr1 gene polymorphisms
03/27/2003WO2003025224A1 Differential gene expression in schizophrenia
03/27/2003WO2003025222A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003WO2003025221A1 Compositions and methods to identify haplotypes
03/27/2003WO2003025220A2 Fusion proteins useful for detecting analytes
03/27/2003WO2003025219A2 Method for sequencing nucleic acids
03/27/2003WO2003025218A2 Methods and yeast strains for screening antifungal agents
03/27/2003WO2003025217A1 Prognostic method
03/27/2003WO2003025216A1 Molecular typing of group b streptococci
03/27/2003WO2003025215A1 Detection of dna methylation
03/27/2003WO2003025214A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
03/27/2003WO2003025213A2 Yeast proteome analysis
03/27/2003WO2003025212A2 Method for detecting sepsis
03/27/2003WO2003025211A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003WO2003025208A1 Method for determining the presence of bacteria resistant to cell lysing antibiotics
03/27/2003WO2003025207A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives
03/27/2003WO2003025204A2 Biochip assembly, sensor assembly and method for operating a biochip assembly
03/27/2003WO2003025203A2 Prediction of cancer by detection of atm mutations
03/27/2003WO2003025202A2 Engineered templates and their use in single primer amplification
03/27/2003WO2003025201A2 Methods of using 5433, a human calcium channel family member
03/27/2003WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor
03/27/2003WO2003025198A2 Regulatory single nucleotide polymorphisms and methods therefor
03/27/2003WO2003025195A2 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof
03/27/2003WO2003025192A2 Membrane transportable fluorescent substrates
03/27/2003WO2003025174A2 Regulation of human mrp1-like protein
03/27/2003WO2003025152A2 IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE
03/27/2003WO2003025150A2 Lipid-associated molecules
03/27/2003WO2003025145A2 Nanomachine compositions and methods of use
03/27/2003WO2003025142A2 Novel nucleic acids and secreted polypeptides
03/27/2003WO2003025141A2 Genetic analysis for stratification of cancer risk
03/27/2003WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003WO2003025138A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003WO2003025135A2 Genes associated with malignant neoplasms
03/27/2003WO2003025132A2 Dna polymerases and mutants thereof
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
03/27/2003WO2003025128A2 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
03/27/2003WO2003025127A2 Chromogenic in situ hybridization methods, kits, and compositions
03/27/2003WO2003025123A2 Dna: a medium for long-term information storage specification
03/27/2003WO2003025122A2 Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment
03/27/2003WO2003025117A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003WO2003025115A1 Small molecule substrate based enzyme activity assays
03/27/2003WO2003025013A1 Asparagine hydroxylation of the cad domain of a hif protein
03/27/2003WO2003025006A2 Purified polypeptides involved in co-factor metabolism
03/27/2003WO2003024987A1 Antisense modulation of fibroblast growth factor receptor 2 expression
03/27/2003WO2003024954A1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna
03/27/2003WO2003024491A2 Kits and methods for determining the effectiveness of sterilization or disinfection processes
03/27/2003WO2003024388A2 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003WO2003024386A2 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003WO2003024314A2 Methods and compositions for detection of single nucleotide polymorphisms
03/27/2003WO2003004989A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
03/27/2003WO2003000012A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
03/27/2003WO2002101358A9 Multiplexed detection methods
03/27/2003WO2002098889A3 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002095050A3 Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
03/27/2003WO2002092837A9 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
03/27/2003WO2002092009A3 A method of characterizing a homeopathic preparation
03/27/2003WO2002086084A3 Sequence characteristics of bladder cancer
03/27/2003WO2002083870A3 Pufa polyketide synthase systems and uses thereof
03/27/2003WO2002068927A3 Using viruses to detect or purify proteins
03/27/2003WO2002068633A3 Compositions and methods relating to lung specific genes and proteins
03/27/2003WO2002061144A3 Brain tumor diagnosis and outcome prediction
03/27/2003WO2002061143A3 Comparative analysis of nucleic acids using population tagging
03/27/2003WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002046414A3 Human g-protein coupled receptor expressed highly in kidney
03/27/2003WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002044326A3 Methods for detection of a target nucleic acid by capture
03/27/2003WO2002044195A3 Method for base sequencing and biologically active nucleic acids
03/27/2003WO2002038773A3 A human phospholipase c and uses thereof
03/27/2003WO2002036821A3 Method for the amplification and optional characterisation of nucleic acids
03/27/2003WO2002034201A3 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
03/27/2003WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002033084A3 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
03/27/2003WO2002026951A3 Oxidoreductases
03/27/2003WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002022076A3 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/27/2003WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof
03/27/2003WO2002015949A9 Device for identifying the presence of a nucleotide sequence in a dna sample
1 ... 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 ... 3003